KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Assets Average (2016 - 2025)

Pacira BioSciences has reported Assets Average over the past 15 years, most recently at $1.3 billion for Q4 2025.

  • Quarterly results put Assets Average at $1.3 billion for Q4 2025, down 16.67% from a year ago — trailing twelve months through Dec 2025 was $1.3 billion (down 16.67% YoY), and the annual figure for FY2025 was $1.4 billion, down 9.89%.
  • Assets Average for Q4 2025 was $1.3 billion at Pacira BioSciences, down from $1.4 billion in the prior quarter.
  • Over the last five years, Assets Average for PCRX hit a ceiling of $2.0 billion in Q1 2022 and a floor of $1.3 billion in Q1 2021.
  • Median Assets Average over the past 5 years was $1.6 billion (2025), compared with a mean of $1.6 billion.
  • Biggest five-year swings in Assets Average: skyrocketed 55.05% in 2021 and later decreased 19.21% in 2023.
  • Pacira BioSciences' Assets Average stood at $1.7 billion in 2021, then decreased by 0.46% to $1.7 billion in 2022, then fell by 8.98% to $1.6 billion in 2023, then decreased by 1.08% to $1.5 billion in 2024, then decreased by 16.67% to $1.3 billion in 2025.
  • The last three reported values for Assets Average were $1.3 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.6 billion (Q2 2025) per Business Quant data.